Injection site is warm to the touch; Injection site is raised; Maternal exposure during pregnancy; Rash at the injection site; Lethargic; Fever; Chills; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), VACCINATION SITE WARMTH (Injection site is warm to the touch), PYREXIA (Fever), CHILLS (Chills) and VACCINATION SITE RASH (Rash at the injection site) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 11-Oct-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 12-Oct-2021, the patient experienced LETHARGY (Lethargic). On 13-Oct-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site is warm to the touch), VACCINATION SITE SWELLING (Injection site is raised) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). At the time of the report, LETHARGY (Lethargic), VACCINATION SITE WARMTH (Injection site is warm to the touch), PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE SWELLING (Injection site is raised) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) outcome was unknown.            Relevant concomitant medications were not reported.  Treatment information was not provided.  CC: This case concerns a 29 year old female , with no reported medical history , who experienced the non-serious , unexpected event of Maternal exposure during pregnancy( the AOG of the pregnancy during the time of vaccination with the 2nd dose is unknown)  and expected events of fever and chills which occurred on the same day after vaccination with the 2nd dose of mRNA -1273(Moderna). The day after vaccination the patient experienced non-serious unexpected event of lethargy and the 2 days after expected event of vaccination site rash  and on unknown date vaccination site swelling  and  unexpected event of vaccination site warmth .  The re-challenge for this case is not applicable. The benefit-risk relationship of mRNA-1273 (Moderna) is not affected by this report.; Sender's Comments: This case concerns a 29 year old female , with no reported medical history , who experienced the non-serious , unexpected event of Maternal exposure during pregnancy( the AOG of the pregnancy during the time of vaccination with the 2nd dose is unknown)  and expected events of fever and chills which occurred on the same day after vaccination with the 2nd dose of mRNA -1273(Moderna). The day after vaccination the patient experienced non-serious unexpected event of lethargy and the 2 days after expected event of vaccination site rash  and on unknown date vaccination site swelling  and  unexpected event of vaccination site warmth .  The re-challenge for this case is not applicable. The benefit-risk relationship of mRNA-1273 (Moderna) is not affected by this report.